Financhill
Sell
46

NTRB Quote, Financials, Valuation and Earnings

Last price:
$4.67
Seasonality move :
45.93%
Day range:
$4.57 - $4.74
52-week range:
$2.98 - $9.42
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
23.65x
P/B ratio:
7.64x
Volume:
5.1K
Avg. volume:
21.4K
1-year change:
52.27%
Market cap:
$57.6M
Revenue:
$2.1M
EPS (TTM):
-$3.07

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
NTRB
Nutriband, Inc.
$675K -$0.17 4.52% -54.85% $15.00
IVF
INVO Fertility, Inc.
$1.8M -- -8.8% -- --
NMTC
NeuroOne Medical Technologies Corp.
$2.5M -- -54.48% -57.14% $2.23
NVNO
enVVeno Medical Corp.
-- -$0.28 -- -9.68% $12.50
SINT
SINTX Technologies, Inc.
$200K -$0.55 -44.65% -56.43% $12.25
XAIR
Beyond Air, Inc.
$2.5M -$0.26 243.81% -8.29% $10.33
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
NTRB
Nutriband, Inc.
$4.74 $15.00 $57.6M -- $0.00 0% 23.65x
IVF
INVO Fertility, Inc.
$0.87 -- $13.2M -- $0.00 0% 0.02x
NMTC
NeuroOne Medical Technologies Corp.
$0.77 $2.23 $38.6M -- $0.00 0% 2.54x
NVNO
enVVeno Medical Corp.
$0.35 $12.50 $7.2M -- $0.00 0% 473.07x
SINT
SINTX Technologies, Inc.
$3.54 $12.25 $13.6M -- $0.00 0% 6.00x
XAIR
Beyond Air, Inc.
$0.82 $10.33 $3.8M -- $0.00 0% 3.66x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
NTRB
Nutriband, Inc.
3.31% 2.796 0.32% 7.07x
IVF
INVO Fertility, Inc.
41.99% -0.446 10.12% 0.07x
NMTC
NeuroOne Medical Technologies Corp.
3.64% 2.039 0.6% 3.40x
NVNO
enVVeno Medical Corp.
2.62% 2.197 4.32% 12.90x
SINT
SINTX Technologies, Inc.
45.47% 1.079 22.94% 1.47x
XAIR
Beyond Air, Inc.
48.09% 1.510 106.48% 2.68x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
NTRB
Nutriband, Inc.
$63K -$3.9M -159.71% -164.64% -1121.15% -$1.8M
IVF
INVO Fertility, Inc.
$492.6K -$1.6M -188.23% -471.28% -93.08% -$1.8M
NMTC
NeuroOne Medical Technologies Corp.
$1.5M -$1.4M -83.42% -89.54% -50.02% -$1.5M
NVNO
enVVeno Medical Corp.
-$120K -$4.9M -56.26% -57.7% -- -$4.4M
SINT
SINTX Technologies, Inc.
-$66K -$3.4M -115.95% -208.36% -1612.98% -$2.6M
XAIR
Beyond Air, Inc.
-$298K -$7.7M -126.53% -220.61% -421.4% -$4.7M

Nutriband, Inc. vs. Competitors

  • Which has Higher Returns NTRB or IVF?

    INVO Fertility, Inc. has a net margin of -1118.87% compared to Nutriband, Inc.'s net margin of -150.51%. Nutriband, Inc.'s return on equity of -164.64% beat INVO Fertility, Inc.'s return on equity of -471.28%.

    Company Gross Margin Earnings Per Share Invested Capital
    NTRB
    Nutriband, Inc.
    18.2% -$0.32 $7.8M
    IVF
    INVO Fertility, Inc.
    28.04% -$6.14 $10.1M
  • What do Analysts Say About NTRB or IVF?

    Nutriband, Inc. has a consensus price target of $15.00, signalling upside risk potential of 216.46%. On the other hand INVO Fertility, Inc. has an analysts' consensus of -- which suggests that it could grow by 16375.97%. Given that INVO Fertility, Inc. has higher upside potential than Nutriband, Inc., analysts believe INVO Fertility, Inc. is more attractive than Nutriband, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    NTRB
    Nutriband, Inc.
    1 0 0
    IVF
    INVO Fertility, Inc.
    0 0 0
  • Is NTRB or IVF More Risky?

    Nutriband, Inc. has a beta of 1.907, which suggesting that the stock is 90.735% more volatile than S&P 500. In comparison INVO Fertility, Inc. has a beta of 2.540, suggesting its more volatile than the S&P 500 by 153.97%.

  • Which is a Better Dividend Stock NTRB or IVF?

    Nutriband, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. INVO Fertility, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nutriband, Inc. pays -- of its earnings as a dividend. INVO Fertility, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios NTRB or IVF?

    Nutriband, Inc. quarterly revenues are $346.1K, which are smaller than INVO Fertility, Inc. quarterly revenues of $1.8M. Nutriband, Inc.'s net income of -$3.9M is lower than INVO Fertility, Inc.'s net income of -$2.6M. Notably, Nutriband, Inc.'s price-to-earnings ratio is -- while INVO Fertility, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nutriband, Inc. is 23.65x versus 0.02x for INVO Fertility, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NTRB
    Nutriband, Inc.
    23.65x -- $346.1K -$3.9M
    IVF
    INVO Fertility, Inc.
    0.02x -- $1.8M -$2.6M
  • Which has Higher Returns NTRB or NMTC?

    NeuroOne Medical Technologies Corp. has a net margin of -1118.87% compared to Nutriband, Inc.'s net margin of -59.08%. Nutriband, Inc.'s return on equity of -164.64% beat NeuroOne Medical Technologies Corp.'s return on equity of -89.54%.

    Company Gross Margin Earnings Per Share Invested Capital
    NTRB
    Nutriband, Inc.
    18.2% -$0.32 $7.8M
    NMTC
    NeuroOne Medical Technologies Corp.
    55.77% -$0.03 $7.3M
  • What do Analysts Say About NTRB or NMTC?

    Nutriband, Inc. has a consensus price target of $15.00, signalling upside risk potential of 216.46%. On the other hand NeuroOne Medical Technologies Corp. has an analysts' consensus of $2.23 which suggests that it could grow by 190.55%. Given that Nutriband, Inc. has higher upside potential than NeuroOne Medical Technologies Corp., analysts believe Nutriband, Inc. is more attractive than NeuroOne Medical Technologies Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    NTRB
    Nutriband, Inc.
    1 0 0
    NMTC
    NeuroOne Medical Technologies Corp.
    1 0 0
  • Is NTRB or NMTC More Risky?

    Nutriband, Inc. has a beta of 1.907, which suggesting that the stock is 90.735% more volatile than S&P 500. In comparison NeuroOne Medical Technologies Corp. has a beta of 0.703, suggesting its less volatile than the S&P 500 by 29.673%.

  • Which is a Better Dividend Stock NTRB or NMTC?

    Nutriband, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NeuroOne Medical Technologies Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nutriband, Inc. pays -- of its earnings as a dividend. NeuroOne Medical Technologies Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios NTRB or NMTC?

    Nutriband, Inc. quarterly revenues are $346.1K, which are smaller than NeuroOne Medical Technologies Corp. quarterly revenues of $2.7M. Nutriband, Inc.'s net income of -$3.9M is lower than NeuroOne Medical Technologies Corp.'s net income of -$1.6M. Notably, Nutriband, Inc.'s price-to-earnings ratio is -- while NeuroOne Medical Technologies Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nutriband, Inc. is 23.65x versus 2.54x for NeuroOne Medical Technologies Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NTRB
    Nutriband, Inc.
    23.65x -- $346.1K -$3.9M
    NMTC
    NeuroOne Medical Technologies Corp.
    2.54x -- $2.7M -$1.6M
  • Which has Higher Returns NTRB or NVNO?

    enVVeno Medical Corp. has a net margin of -1118.87% compared to Nutriband, Inc.'s net margin of --. Nutriband, Inc.'s return on equity of -164.64% beat enVVeno Medical Corp.'s return on equity of -57.7%.

    Company Gross Margin Earnings Per Share Invested Capital
    NTRB
    Nutriband, Inc.
    18.2% -$0.32 $7.8M
    NVNO
    enVVeno Medical Corp.
    -- -$0.23 $30.2M
  • What do Analysts Say About NTRB or NVNO?

    Nutriband, Inc. has a consensus price target of $15.00, signalling upside risk potential of 216.46%. On the other hand enVVeno Medical Corp. has an analysts' consensus of $12.50 which suggests that it could grow by 3423.11%. Given that enVVeno Medical Corp. has higher upside potential than Nutriband, Inc., analysts believe enVVeno Medical Corp. is more attractive than Nutriband, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    NTRB
    Nutriband, Inc.
    1 0 0
    NVNO
    enVVeno Medical Corp.
    0 1 0
  • Is NTRB or NVNO More Risky?

    Nutriband, Inc. has a beta of 1.907, which suggesting that the stock is 90.735% more volatile than S&P 500. In comparison enVVeno Medical Corp. has a beta of 1.063, suggesting its more volatile than the S&P 500 by 6.264%.

  • Which is a Better Dividend Stock NTRB or NVNO?

    Nutriband, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. enVVeno Medical Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nutriband, Inc. pays -- of its earnings as a dividend. enVVeno Medical Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios NTRB or NVNO?

    Nutriband, Inc. quarterly revenues are $346.1K, which are larger than enVVeno Medical Corp. quarterly revenues of --. Nutriband, Inc.'s net income of -$3.9M is higher than enVVeno Medical Corp.'s net income of -$4.5M. Notably, Nutriband, Inc.'s price-to-earnings ratio is -- while enVVeno Medical Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nutriband, Inc. is 23.65x versus 473.07x for enVVeno Medical Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NTRB
    Nutriband, Inc.
    23.65x -- $346.1K -$3.9M
    NVNO
    enVVeno Medical Corp.
    473.07x -- -- -$4.5M
  • Which has Higher Returns NTRB or SINT?

    SINTX Technologies, Inc. has a net margin of -1118.87% compared to Nutriband, Inc.'s net margin of -1701.44%. Nutriband, Inc.'s return on equity of -164.64% beat SINTX Technologies, Inc.'s return on equity of -208.36%.

    Company Gross Margin Earnings Per Share Invested Capital
    NTRB
    Nutriband, Inc.
    18.2% -$0.32 $7.8M
    SINT
    SINTX Technologies, Inc.
    -31.73% -$3.46 $7.5M
  • What do Analysts Say About NTRB or SINT?

    Nutriband, Inc. has a consensus price target of $15.00, signalling upside risk potential of 216.46%. On the other hand SINTX Technologies, Inc. has an analysts' consensus of $12.25 which suggests that it could grow by 246.05%. Given that SINTX Technologies, Inc. has higher upside potential than Nutriband, Inc., analysts believe SINTX Technologies, Inc. is more attractive than Nutriband, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    NTRB
    Nutriband, Inc.
    1 0 0
    SINT
    SINTX Technologies, Inc.
    2 0 0
  • Is NTRB or SINT More Risky?

    Nutriband, Inc. has a beta of 1.907, which suggesting that the stock is 90.735% more volatile than S&P 500. In comparison SINTX Technologies, Inc. has a beta of 0.633, suggesting its less volatile than the S&P 500 by 36.717%.

  • Which is a Better Dividend Stock NTRB or SINT?

    Nutriband, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SINTX Technologies, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nutriband, Inc. pays -- of its earnings as a dividend. SINTX Technologies, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios NTRB or SINT?

    Nutriband, Inc. quarterly revenues are $346.1K, which are larger than SINTX Technologies, Inc. quarterly revenues of $208K. Nutriband, Inc.'s net income of -$3.9M is lower than SINTX Technologies, Inc.'s net income of -$3.5M. Notably, Nutriband, Inc.'s price-to-earnings ratio is -- while SINTX Technologies, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nutriband, Inc. is 23.65x versus 6.00x for SINTX Technologies, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NTRB
    Nutriband, Inc.
    23.65x -- $346.1K -$3.9M
    SINT
    SINTX Technologies, Inc.
    6.00x -- $208K -$3.5M
  • Which has Higher Returns NTRB or XAIR?

    Beyond Air, Inc. has a net margin of -1118.87% compared to Nutriband, Inc.'s net margin of -454.24%. Nutriband, Inc.'s return on equity of -164.64% beat Beyond Air, Inc.'s return on equity of -220.61%.

    Company Gross Margin Earnings Per Share Invested Capital
    NTRB
    Nutriband, Inc.
    18.2% -$0.32 $7.8M
    XAIR
    Beyond Air, Inc.
    -16.39% -$1.25 $24.9M
  • What do Analysts Say About NTRB or XAIR?

    Nutriband, Inc. has a consensus price target of $15.00, signalling upside risk potential of 216.46%. On the other hand Beyond Air, Inc. has an analysts' consensus of $10.33 which suggests that it could grow by 1165.56%. Given that Beyond Air, Inc. has higher upside potential than Nutriband, Inc., analysts believe Beyond Air, Inc. is more attractive than Nutriband, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    NTRB
    Nutriband, Inc.
    1 0 0
    XAIR
    Beyond Air, Inc.
    2 1 0
  • Is NTRB or XAIR More Risky?

    Nutriband, Inc. has a beta of 1.907, which suggesting that the stock is 90.735% more volatile than S&P 500. In comparison Beyond Air, Inc. has a beta of 0.304, suggesting its less volatile than the S&P 500 by 69.581%.

  • Which is a Better Dividend Stock NTRB or XAIR?

    Nutriband, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Beyond Air, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nutriband, Inc. pays -- of its earnings as a dividend. Beyond Air, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios NTRB or XAIR?

    Nutriband, Inc. quarterly revenues are $346.1K, which are smaller than Beyond Air, Inc. quarterly revenues of $1.8M. Nutriband, Inc.'s net income of -$3.9M is higher than Beyond Air, Inc.'s net income of -$8.3M. Notably, Nutriband, Inc.'s price-to-earnings ratio is -- while Beyond Air, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nutriband, Inc. is 23.65x versus 3.66x for Beyond Air, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NTRB
    Nutriband, Inc.
    23.65x -- $346.1K -$3.9M
    XAIR
    Beyond Air, Inc.
    3.66x -- $1.8M -$8.3M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock